Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Selleck Chemical LLC TAK-285 S2784-5mg
SDP

Catalog No. 503112471
Encompass_Preferred

TAK-285 is a novel dual HER2 and EGFR(HER1) inhibitor with IC50 of 17 nM and 23 nM 10-fold selectivity for HER1/2 than HER4 less potent to MEK1/5 c-Met Aurora B Lck CSK etc Phase 1

Catalog No. 50-311-2471 Supplier Selleck Chemical LLC Supplier No. S27845MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

TAK-285 is a novel dual HER2 and EGFR(HER1) inhibitor with IC50 of 17 nM and 23 nM 10-fold selectivity for HER1/2 than HER4 less potent to MEK1/5 c-Met Aurora B Lck CSK etc Phase 1

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.